Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. - Ana da Silva Filipe, Ashley Sanchez Sevilla Uruchurtu, Thushan de Silva, Maria Zambon, Murray Wham, Libby van Tonder, Eve Wilcock, Nicola Wrobel, Andrew Ustianowski, Nick Vallotton, Lisa Vincent-Smith, Shico Visuvanathan, Alan Vuylsteke, Sam Waddy, Rachel Wake - Dissemin

Language
Login

Published in

American Association for the Advancement of Science, Science Immunology, 57(6), 2021

DOI: 10.1126/sciimmunol.abg9873

Links

Tools

Export citation

Search in Google Scholar

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.

Journal article published in 2021 by Ana da Silva Filipe, Ashley Sanchez Sevilla Uruchurtu, Thushan de Silva, Maria Zambon, Murray Wham, Libby van Tonder, Eve Wilcock, Nicola Wrobel, Andrew Ustianowski, Nick Vallotton, Lisa Vincent-Smith, Shico Visuvanathan, Alan Vuylsteke, Sam Waddy, Rachel Wake and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO

Abstract

GM-CSF is elevated early, scaled with severity, and is central to the inflammatory response in COVID-19, but not severe influenza.